Dittrich, A.T.M.; Smeets, N.J.L.; de Jong, E.F.M.; Kämink, J.L.; Kroeze, Y.; Draaisma, J.M.T.; van Puijenbroek, E.P.; te Loo, D.M.W.M.
Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care. Pharmaceuticals 2022, 15, 1148.
https://doi.org/10.3390/ph15091148
AMA Style
Dittrich ATM, Smeets NJL, de Jong EFM, Kämink JL, Kroeze Y, Draaisma JMT, van Puijenbroek EP, te Loo DMWM.
Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care. Pharmaceuticals. 2022; 15(9):1148.
https://doi.org/10.3390/ph15091148
Chicago/Turabian Style
Dittrich, Anne T. M., Nori J. L. Smeets, Emma F. M. de Jong, Juliët L. Kämink, Yvet Kroeze, Jos M. Th. Draaisma, Eugène P. van Puijenbroek, and D. Maroeska W. M. te Loo.
2022. "Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care" Pharmaceuticals 15, no. 9: 1148.
https://doi.org/10.3390/ph15091148
APA Style
Dittrich, A. T. M., Smeets, N. J. L., de Jong, E. F. M., Kämink, J. L., Kroeze, Y., Draaisma, J. M. T., van Puijenbroek, E. P., & te Loo, D. M. W. M.
(2022). Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care. Pharmaceuticals, 15(9), 1148.
https://doi.org/10.3390/ph15091148
